Skip to main content

Immunoglobulin Purification by Caprylic Acid

  • Protocol
  • First Online:
Protein Downstream Processing

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1129))

Abstract

At laboratory scale, several methods for the purification of immunoglobulins from plasma or serum are available. However, not all of them are equally applicable when the scale-up to the level of the pharmaceutical industry is intended. In this case, among other factors, it must be taken into account the performance and the cost and quality of the end product. Here we present a method of purification based on the differential precipitation of plasma proteins with caprylic acid in a single step that is simple and cheap and can be easily scaled up. This methodology has been successfully applied to the development and production of pharmaceutical product, such as therapeutic antisera where immunoglobulin fraction is the unique active pharmaceutical ingredient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McKinney MM, Parkinson A (1987) A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid. J Immunol Methods 96:271–278

    Article  CAS  PubMed  Google Scholar 

  2. Theakston RDG, Warrell DA, Griffiths E (2003) Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 41:541–557

    Article  CAS  PubMed  Google Scholar 

  3. León G, Lomonte B, Gutiérrez JM (2005) Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols. Toxicon 45:123–128

    Article  PubMed  Google Scholar 

  4. Morais V, Massaldi H (2005) Effect of pepsin digestion on the antivenom activity of equine immunoglobulins. Toxicon 46:876–882

    Article  CAS  PubMed  Google Scholar 

  5. Otero R, León G, Gutiérrez JM et al (2006) Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without β-propiolactone, in the treatment of Bothrops asper bites in Colombia. Trans R Soc Trop Med Hyg 100:1173–1182

    Article  CAS  PubMed  Google Scholar 

  6. Burnouf T, Griffiths E, Padilla A et al (2004) Assessment of the viral safety of antivenoms fractionated from equine plasma. Biologicals 32:115–128

    Article  CAS  PubMed  Google Scholar 

  7. Chanutin A, Curnish RR (1960) The precipitation of plasma proteins by short-chain fatty acids. Arch Biochem Biophys 89:218–220

    Article  CAS  PubMed  Google Scholar 

  8. Steimbuch M, Audran R (1969) The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys 134:279–284

    Article  Google Scholar 

  9. Rojas G, Jimenez JM, Gutierrez JM (1994) Caprylic acid fractionation of hyperimmune horse plasma: description of a single procedure for antivenom production. Toxicon 32:351–363

    Article  CAS  PubMed  Google Scholar 

  10. Raweerith R, Ratanabanangkoon K (2003) Fractionation of equine antivenom using caprylic acid precipitation in combination with cationic ion-exchange chromatography. J Immunol Methods 282:63–72

    Article  CAS  PubMed  Google Scholar 

  11. Morais V, Massaldi H (2006) Economic evaluation of snake antivenom production in the public system. J Venom Anim Toxins Incl Trop Dis 12:497–511

    Google Scholar 

  12. Harms AJ (1948) The purification of antitoxic plasmas by enzyme treatment and heat denaturation. Biochem J 42:390–397

    CAS  PubMed Central  PubMed  Google Scholar 

  13. Boyer PD, Lum FG, Ballou GA et al (1946) The combination of fatty acids and related compounds with serum albumin. I. Stabilization against heat denaturation. J Biol Chem 162:181–198

    CAS  PubMed  Google Scholar 

  14. Yu MW, Finlayson JS (1984) Stabilization of human albumin by caprylate and acetyltryptophanate. Vox Sang 47:28–40

    Article  CAS  PubMed  Google Scholar 

  15. Lebing W, Remington KM, Schreiner C et al (2003) Properties of a new intravenous immunoglobulin (IGIV-C, 10 %) produced by virus inactivation with caprylate and column chromatography. Vox Sang 84:193–201

    Article  CAS  PubMed  Google Scholar 

  16. Otero-Patiño R, Cardozo J, Higashi H et al (1998) A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. Am J Trop Med Hyg 58:183–189

    PubMed  Google Scholar 

  17. Otero-Patiño R, Gutierrez JM, Rojas G et al (1997) A randomized, blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites Colombia: correlation between safety and biochemical characteristics of antivenoms. Toxicon 37:895–908

    Article  Google Scholar 

  18. Boyer PD, Ballou GA, Luck JM (1947) The combination of fatty acids and related compounds with serum albumin. III. The nature and extent of the combination. J Biol Chem 167:407–424

    CAS  PubMed  Google Scholar 

  19. Van Oss CJ, Good RJ, Chaudhury MK (1986) Solubility of proteins. J Protein Chem 5:385–405

    Article  Google Scholar 

  20. Morais V, Massaldi H (2012) A model mechanism for protein precipitation by caprylic acid: application to plasma purification. Biotechnol Appl Biochem 59:50–54

    Article  CAS  PubMed  Google Scholar 

  21. Harlow E, Lane D (1986) Antibodies. A laboratory manual. Cold Spring Harbor Laboratory, New York

    Google Scholar 

  22. Nudel BC, Perdoménico C, Iácono R et al (2012) Optimization by factorial analysis of caprylic acid precipitation of non-immunoglobulins from hyperimmune equine plasma for antivenom preparation. Toxicon 59:68–73

    Article  CAS  PubMed  Google Scholar 

  23. Gutiérrez JM, Rojas E, Quesada L et al (2005) Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa. Trans R Soc Trop Med Hyg 99:468–475

    Article  PubMed  Google Scholar 

  24. Herrera M, Meneses F, Gutiérrez JM et al (2009) Development and validation of a reverse phase HPLC method for the determination of caprylic acid in formulations of therapeutic immunoglobulins and its application to antivenom production. Biologicals 37:230–234

    Article  CAS  PubMed  Google Scholar 

  25. WHO (2010) WHO guidelines for the production, control and regulation of snake antivenom immunoglobulins. http://www.who.int/bloodproducts/snake_antivenoms/snakeantivenomguideline.pdf. Accessed 13 Feb 2013

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Victor Morais .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Morais, V., Berasain, P., Massaldi, H. (2014). Immunoglobulin Purification by Caprylic Acid. In: Labrou, N. (eds) Protein Downstream Processing. Methods in Molecular Biology, vol 1129. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-977-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-977-2_13

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-976-5

  • Online ISBN: 978-1-62703-977-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics